These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38222154)

  • 1. Prevalence of Latent Tuberculosis Infection Among Rheumatology Patients and Management Practices in the United Arab Emirates: A Single-Center Retrospective Cohort Study.
    Al Nokhatha S; AlKindi F; Alfalasi M; Abdelsalhen M; AlKhyeli F; Alsaber AR
    Cureus; 2023 Dec; 15(12):e50581. PubMed ID: 38222154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective cross-sectional study of tuberculosis screening in United Arab Emirates.
    Almarzooqi F; Alkhemeiri A; Aljaberi A; Hashmey R; Zoubeidi T; Souid AK
    Int J Infect Dis; 2018 May; 70():81-85. PubMed ID: 29526607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents.
    Kim KH; Lee SW; Chung WT; Kim BG; Woo KS; Han JY; Kim JM
    Korean J Lab Med; 2011 Oct; 31(4):271-8. PubMed ID: 22016681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
    Hsia EC; Schluger N; Cush JJ; Chaisson RE; Matteson EL; Xu S; Beutler A; Doyle MK; Hsu B; Rahman MU
    Arthritis Rheum; 2012 Jul; 64(7):2068-77. PubMed ID: 22238071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of predictors influencing indeterminate whole-blood interferon-gamma release assay results in patients with rheumatic diseases.
    Jung HJ; Kim TJ; Kim HS; Cho YN; Jin HM; Kim MJ; Kang JH; Park KJ; Lee SJ; Lee SS; Kwon YS; Yoo DH; Kee SJ; Park YW
    Rheumatol Int; 2014 Dec; 34(12):1711-20. PubMed ID: 24816858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Interferon-Gamma Release Assays for Tuberculosis Screening in Pediatric Inflammatory Bowel Disease.
    Stevens JP; Ballengee CR; Chandradevan R; Thompson AB; Schoen BT; Kugathasan S; Sauer CG
    J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):e111-e116. PubMed ID: 31261245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of progression to active tuberculosis for indeterminate interferon-gamma release assay in immunocompromised individuals: a systematic review and meta-analysis.
    Zhou G; Luo S; He J; Chen N; Zhang Y; Cai S; Guo X; Song C
    Clin Microbiol Infect; 2023 Nov; 29(11):1375-1384. PubMed ID: 37422080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?
    Palacios CF; Chowdhary V; Hao R; Danve A; Malinis M
    PLoS One; 2024; 19(7):e0306337. PubMed ID: 38959249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients.
    Wang PH; Lin CH; Chang TH; Wu CS
    BMC Pulm Med; 2020 Aug; 20(1):232. PubMed ID: 32867745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Indeterminate Outcome on Interferon Gamma Release Assay in Non-US-Born Persons Screened for Latent Tuberculosis Infection.
    Sharninghausen JC; Shapiro AE; Koelle DM; Kim HN
    Open Forum Infect Dis; 2018 Aug; 5(8):ofy184. PubMed ID: 30151410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
    Kwakernaak AJ; Houtman PM; Weel JF; Spoorenberg JP; Jansen TL
    Clin Rheumatol; 2011 Apr; 30(4):505-10. PubMed ID: 20737179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome.
    Compagno M; Navarra A; Campogiani L; Coppola L; Rossi B; Iannetta M; Malagnino V; Parisi SG; Mariotti B; Cerretti R; Arcese W; Goletti D; Andreoni M; Sarmati L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.